Quimioterapia antineoplásica e nutrição: uma relação complexa

Ferreira, Noeli Marchioro Liston Andrade; Scarpa, Ägatha; da Silva, D'Agima Alves
December 2008
Revista Eletronica de Enfermagem;2008, Vol. 10 Issue 4, p1026
Academic Journal
The chemotherapy uses chemical compounds with the goal of eradicating tumors, but for lack of specificity for tumor cells attacks also normal cells, bringing side effects mainly to the gastrointestinal tract, causing damage to the nutritional conditions of the customer, generating deficiencies and unpleasant symptoms. This study descriptive and exploratory, held in 2006 in a council of the State of Sao Paulo/Brazil aimed at to identifie the nutritional changes made by the patient with cancer in chemotherapy treatment, using interview and semi-structured questionnaire. Were found 13 adults aged over 50 years, accompanied by various types of cancer in treatment. With the use of chemotherapy the patients had nausea, anorexia, fatigue and discomfort with the smell of food, cold, and fast feeling of satiety, dry mouth and mucositis. The assessment revealed: alopecia, stained nails, skin discords and dehydrated, changes in physical abilities to work and loss of weight in most of them. Patients reported low water intake, reduction in food intake, intolerance to meat and beans, increased consumption of fruits, vegetables and juices. These data indicates that the chemotherapy treatment works for the modification of the patient with cancer nutritional pointing to the need for early intervention aimed at the success of the therapeutic imbalances.


Related Articles

  • Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis. Sakamoto, Takeshi; Yasui, Hirofumi; Boku, Narikazu; Onozawa, Yusuke; Hironaka, Shuichi; Fukutomi, Akira; Yamazaki, Kentaro; Taku, Keisei; Machida, Nozomu; Todaka, Akiko; Tomita, Hideharu; Tsushima, Takahiro; Taniguchi, Hiroya; Hamauchi, Satoshi // International Journal of Clinical Oncology;Jun2010, Vol. 15 Issue 3, p287 

    Efficacy and safety of irinotecan and cisplatin administration every 2 weeks (biweekly regimen) or 4 weeks (4-weekly regimen) in patients with pretreated unresectable or recurrent gastric cancer was retrospectively evaluated. Study patients comprised two cohorts: cohort 1, consisting of 31...

  • Establishing a cancer nutrition rehabilitation program (CNRP) for ambulatory patients attending an Australian cancer center. Glare, Paul; Jongs, Wendy; Zafiropoulos, Bill // Supportive Care in Cancer;Apr2011, Vol. 19 Issue 4, p445 

    Purpose: To establish a multidisciplinary Cancer Nutrition Rehabilitation Program (CNRP) for the management of the anorexia-cachexia syndrome (ACS) in an Australian cancer center and to evaluate outcomes of 2 months participation in the CNRP Method: Patients were eligible if they had significant...

  • Loss of weight and loss of appetite in advanced cancer: a problem for the patient, the carer, or the health professional? Poole, Karen; Froggatt, Katherine // Palliative Medicine;Oct2002, Vol. 16 Issue 6, p499 

    This paper aims to examine the loss of weight and loss of appetite as 'problems' experienced by patients with advanced cancer and those that care for them. It reports the results of a systematic search of the literature and presents the findings as a narrative review. Research to date has...

  • Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer. Taira, Koichi; Boku, Narikazu; Fukutomi, Akira; Onozawa, Yusuke; Hironaka, Shuichi; Yoshino, Takayuki; Yasui, Hirofumi; Yamazaki, Kentaro; Taku, Keisei; Hashimoto, Takayuki; Nishimura, Tetsuo // Journal of Gastroenterology;2008, Vol. 43 Issue 11, p875 

    Many studies of concurrent chemoradiation therapy with 5-fluorouracil (5-FU) for locally advanced pancreatic cancer have been reported with a median survival time of approximately 10 months. Recently, gemcitabine (GEM) has been administered immediately after chemoradiation. The clinical outcome...

  • Management of weight loss and anorexia. Hopkinson, J. B.; Wright, D. N. M.; Foster, C. // Annals of Oncology;Sep2008 Supplement 7, Vol. 19, p289 

    The article focuses on the management of weight loss and anorexia in people with cancer cachexia syndrome (CCS). It states that since cancer cachexia is different from starvation, it cannot be reversed by food intake alone. It mentions that psychosocial support could improve outcomes for people...

  • Obesity and Cancer. Wolin, Kathleen Y.; Carson, Kenneth; Colditz, Graham A. // Oncologist;Jun2010, Vol. 15 Issue 6, p556 

    Weight, weight gain, and obesity account for approximately 20% of all cancer cases. Evidence on the relation of each to cancer is summarized, including esophageal, thyroid, colon, renal, liver, melanoma, multiple myeloma, rectum, gallbladder, leukemia, lymphoma, and prostate in men; and...

  • Understanding cachexia and excessive weight loss in cancer. Hemming, Laureen; Maher, David // British Journal of Community Nursing;Nov2005, Vol. 10 Issue 11, p492 

    Cachexia, a wasting condition often seen in advanced cancer, is often confused with anorexia but they are two separate conditions. It is evident that cachexia frequently leads to anorexia but anorexia alone cannot cause cachexia. The cachexia syndrome is weight loss with a specific cause...

  • Tumor-induced anorexia and weight loss are mediated by the TGF-β superfamily cytokine MIC-1. Johnen, Heiko; Shu Lin; Kuffner, Tamara; Brown, David A.; Tsai, Vicky Wang-Wei; Bauskin, Asne R.; Liyun Wu; Pankhurst, Greg; Lele Jiang; Junankar, Simon; Hunter, Mark; Fairlie, W. Douglas; Lee, Nicola J.; Enriquez, Ronaldo F.; Baldock, Paul A.; Corey, Eva; Apple, Fred S.; Murakami, MaryAnn M.; En-Ju Lin; Chuansong Wang // Nature Medicine;Nov2007, Vol. 13 Issue 11, p1333 

    Anorexia and weight loss are part of the wasting syndrome of late-stage cancer, are a major cause of morbidity and mortality in cancer, and are thought to be cytokine mediated. Macrophage inhibitory cytokine-1 (MIC-1) is produced by many cancers. Examination of sera from individuals with...

  • Diseases of the alimentary system. Hawkins, Clifford // British Medical Journal;12/4/1976, Vol. 2 Issue 6048, p1373 

    Focuses on anorexia and loss of weight. Symptoms of anorexia; Causes of anorexia; Consideration of insufficient intake as the common cause of loss of weight.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics